BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8711595)

  • 1. [Comments on radical prostatectomy three month after hormone therapy].
    Selvaggi FP; Battaglia M; Martino P; Disabato G; Traficante A; Bufo P
    Minerva Urol Nefrol; 1995 Dec; 47(4):215-7. PubMed ID: 8711595
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
    Hermans BP; Lorge F; Wese FX; Opsomer RJ; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):27-31. PubMed ID: 8659332
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
    Boccon-Gibod L
    Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neoadjuvant hormone therapy with casodex in a dose 150 mg prior to radical prostatectomy in patients with prostatic cancer].
    Rusakov IG; Petrov SB; Alekseev BIa; Veliev EI
    Urologiia; 2004; (4):15-9. PubMed ID: 15457946
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant hormonal and chemotherapy for prostate cancer.
    Lam ET; Glodé LM
    Hematol Oncol Clin North Am; 2013 Dec; 27(6):1189-204, viii. PubMed ID: 24188258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant hormonotherapy in patients with clinically-localized prostate cancer treated by radical prostatectomy: pathological results.
    Têtu B
    Can J Oncol; 1994 Nov; 4 Suppl 1():33-4; discussion 35-6. PubMed ID: 8853487
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Rogers C
    J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14575038
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival.
    Steiner MS
    Curr Urol Rep; 2000 May; 1(1):7-8. PubMed ID: 12084334
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant hormone therapy for prostate cancer.
    Zlotta AR; Schulman CC
    World J Urol; 2000 Jun; 18(3):179-82. PubMed ID: 10926081
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Messing EM
    J Urol; 2003 Nov; 170(5):1955; author reply 1955-6. PubMed ID: 14532828
    [No Abstract]   [Full Text] [Related]  

  • 13. [Integrated (surgical and hormonal) treatment of advanced prostatic carcinoma. Comment on the study and the interview with Edward M. Messing].
    Prayer Galetti T
    Recenti Prog Med; 2001 Feb; 92(2):126-7. PubMed ID: 11294103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radical prostatectomy with neoadjuvant hormone therapy for cT3 prostate cancer].
    Fujimoto H
    Nihon Rinsho; 2005 Feb; 63(2):271-8. PubMed ID: 15714978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
    Jani A; Vogelzang NJ
    J Urol; 2001 Aug; 166(2):631-2. PubMed ID: 11458102
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prognostic factors in patients with prostatic cancer treated with neoadjuvant hormonal therapy and radical prostatectomy].
    Villavicencio Mavrich H; Chéchile Toniolo G; Salinas Duffo D; Muñoz Plaza J; Sorraca Ibáñez YJ
    Arch Esp Urol; 1996 Oct; 49(8):797-806. PubMed ID: 9065276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
    Ehara H; Nakano M; Deguchi T
    Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant hormonal treatment before radical prostatectomy.
    Watson RB; Soloway MS
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):48-55; discussion 55-6. PubMed ID: 8725891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes in early prostate cancer: Part I--adjuvant treatment.
    Mazhar D; Ngan S; Waxman J
    BJU Int; 2006 Oct; 98(4):725-30. PubMed ID: 16978266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.